{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:19:08Z","timestamp":1791148748159,"version":"4.1.0"},"publisher-location":"Dordrecht","reference-count":62,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400778924","type":"print"},{"value":"9789400778931","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T00:00:00Z","timestamp":1386979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T00:00:00Z","timestamp":1386979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-94-007-7893-1_9","type":"book-chapter","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T10:51:16Z","timestamp":1389955876000},"page":"129-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["The Ehlers-Danlos Syndrome"],"prefix":"10.1007","author":[{"given":"Fransiska","family":"Malfait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"De Paepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,14]]},"reference":[{"issue":"1","key":"9_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O","volume":"77","author":"P Beighton","year":"1998","unstructured":"Beighton P et al (1998) Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers- Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 77(1):31\u201337","journal-title":"Am J Med Genet"},{"issue":"1","key":"9_CR2","first-page":"105","volume":"98","author":"SM Smith","year":"2010","unstructured":"Smith SM, Birk DE (2010) Focus on molecules: collagens V and XI. Exp Eye Res 2012 May; 98(1): 105\u2013106","journal-title":"Exp Eye Res"},{"issue":"1","key":"9_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng0195-31","volume":"9","author":"K Andrikopoulos","year":"1995","unstructured":"Andrikopoulos K et al (1995) Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet 9(1):31\u201336","journal-title":"Nat Genet"},{"issue":"3","key":"9_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ng0796-361","volume":"13","author":"HV Toriello","year":"1996","unstructured":"Toriello HV et al (1996) A translocation interrupts the COL5A1 gene in a patient with Ehlers- Danlos syndrome and hypomelanosis of Ito. Nat Genet 13(3):361\u2013365","journal-title":"Nat Genet"},{"issue":"11","key":"9_CR5","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/hmg\/5.11.1733","volume":"5","author":"RJ Wenstrup","year":"1996","unstructured":"Wenstrup RJ et al (1996) A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum Mol Genet 5(11):1733\u20131736","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9_CR6","first-page":"547","volume":"60","author":"A De Paepe","year":"1997","unstructured":"De Paepe A et al (1997) Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet 60(3):547\u2013554","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9_CR7","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1086\/302933","volume":"66","author":"U Schwarze","year":"2000","unstructured":"Schwarze U et al (2000) Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). Am J Hum Genet 66(6):1757\u20131765","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9_CR8","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1086\/302930","volume":"66","author":"RJ Wenstrup","year":"2000","unstructured":"Wenstrup RJ et al (2000) COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. Am J Hum Genet 66(6):1766\u20131776","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/humu.20107","volume":"25","author":"F Malfait","year":"2005","unstructured":"Malfait F et al (2005) The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients. Hum Mutat 25(1):28\u201337","journal-title":"Hum Mutat"},{"issue":"2","key":"9_CR10","doi-asserted-by":"publisher","first-page":"E395","DOI":"10.1002\/humu.20887","volume":"30","author":"S Symoens","year":"2009","unstructured":"Symoens S et al (2009) COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome. Hum Mutat 30(2):E395\u2013E403","journal-title":"Hum Mutat"},{"issue":"5","key":"9_CR11","doi-asserted-by":"publisher","first-page":"e20121","DOI":"10.1371\/journal.pone.0020121","volume":"6","author":"S Symoens","year":"2011","unstructured":"Symoens S et al (2011) A novel splice variant in the N-propeptide of COL5A1 causes an EDS phenotype with severe kyphoscoliosis and eye involvement. PLoS One 6(5):e20121","journal-title":"PLoS One"},{"issue":"10","key":"9_CR12","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/humu.22137","volume":"33","author":"S Symoens","year":"2012","unstructured":"Symoens S et al (2012) Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria. Hum Mutat 33(10):1485\u20131493","journal-title":"Hum Mutat"},{"issue":"5","key":"9_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/ard.32.5.413","volume":"32","author":"P Beighton","year":"1973","unstructured":"Beighton P, Solomon L, Soskolne CL (1973) Articular mobility in an African population. Ann Rheum Dis 32(5):413\u2013418","journal-title":"Ann Rheum Dis"},{"issue":"16","key":"9_CR14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3109\/09638280903514739","volume":"32","author":"L Rombaut","year":"2010","unstructured":"Rombaut L et al (2010) Musculoskeletal complaints, physical activity and health-related quality of life among patients with the Ehlers-Danlos syndrome hypermobility type. Disabil Rehabil 32(16):1339\u20131345","journal-title":"Disabil Rehabil"},{"issue":"7","key":"9_CR15","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/art.30337","volume":"63","author":"L Rombaut","year":"2011","unstructured":"Rombaut L et al (2011) Impairment and impact of pain in female patients with Ehlers-Danlos syndrome: a comparative study with fibromyalgia and rheumatoid arthritis. Arthritis Rheum 63(7):1979\u20131987","journal-title":"Arthritis Rheum"},{"issue":"3","key":"9_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10067-009-1320-y","volume":"29","author":"L Rombaut","year":"2010","unstructured":"Rombaut L et al (2010) Joint position sense and vibratory perception sense in patients with Ehlers-Danlos syndrome type III (hypermobility type). Clin Rheumatol 29(3):289\u2013295","journal-title":"Clin Rheumatol"},{"issue":"10","key":"9_CR17","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/acr.21726","volume":"64","author":"L Rombaut","year":"2012","unstructured":"Rombaut L et al (2012) Muscle mass, muscle strength, functional performance, and physical impairment in women with the hypermobility type of Ehlers-Danlos syndrome. Arthritis Care Res (Hoboken) 64(10):1584\u20131592","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"9_CR18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/BF00201664","volume":"93","author":"I Hausser","year":"1994","unstructured":"Hausser I, Anton-Lamprecht I (1994) Differential ultrastructural aberrations of collagen fibrils in Ehlers- Danlos syndrome types I-IV as a means of diagnostics and classification. Hum Genet 93(4):394\u2013407","journal-title":"Hum Genet"},{"issue":"1","key":"9_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1086\/376564","volume":"73","author":"MC Zweers","year":"2003","unstructured":"Zweers MC et al (2003) Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet 73(1):214\u2013217","journal-title":"Am J Hum Genet"},{"issue":"16","key":"9_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa002939","volume":"345","author":"J Schalkwijk","year":"2001","unstructured":"Schalkwijk J et al (2001) A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 345(16):1167\u20131175","journal-title":"N Engl J Med"},{"issue":"1","key":"9_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/nar\/26.1.253","volume":"26","author":"R Dalgleish","year":"1998","unstructured":"Dalgleish R (1998) The human collagen mutation database 1998. Nucleic Acids Res 26(1):253\u2013255","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"9_CR22","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1086\/324123","volume":"69","author":"U Schwarze","year":"2001","unstructured":"Schwarze U et al (2001) Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV. Am J Hum Genet 69(5):989\u20131001","journal-title":"Am J Hum Genet"},{"issue":"8","key":"9_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/GIM.0b013e3182180c89","volume":"13","author":"DF Leistritz","year":"2011","unstructured":"Leistritz DF et al (2011) COL3A1 haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy. Genet Med 13(8):717\u2013722","journal-title":"Genet Med"},{"issue":"6","key":"9_CR24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1034\/j.1399-0004.2003.00075.x","volume":"63","author":"S Palmeri","year":"2003","unstructured":"Palmeri S et al (2003) Neurological presentation of Ehlers-Danlos syndrome type IV in a family with parental mosaicism. Clin Genet 63(6):510\u2013515","journal-title":"Clin Genet"},{"issue":"1","key":"9_CR25","first-page":"62","volume":"53","author":"DM Milewicz","year":"1993","unstructured":"Milewicz DM et al (1993) Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring. Am J Hum Genet 53(1):62\u201370","journal-title":"Am J Hum Genet"},{"issue":"3","key":"9_CR26","first-page":"497","volume":"51","author":"S Kontusaari","year":"1992","unstructured":"Kontusaari S et al (1992) Substitution of aspartate for glycine 1018 in the type III procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is present in most blood leukocytes of the asymptomatic and mosaic mother. Am J Hum Genet 51(3):497\u2013507","journal-title":"Am J Hum Genet"},{"issue":"4","key":"9_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/BF00194313","volume":"89","author":"AJ Richards","year":"1992","unstructured":"Richards AJ et al (1992) A single base mutation in the gene for type III collagen (COL3A1) converts glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type IV. An unaffected family member is mosaic for the mutation. Hum Genet 89(4):414\u2013418","journal-title":"Hum Genet"},{"issue":"19","key":"9_CR28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJM197205112861901","volume":"286","author":"SR Pinnell","year":"1972","unstructured":"Pinnell SR et al (1972) A heritable disorder of connective tissue. Hydroxylysine-deficient collagen disease. New Engl J Med 286(19):1013\u20131020","journal-title":"New Engl J Med"},{"issue":"5","key":"9_CR29","first-page":"353","volume":"15","author":"HN Yeowell","year":"2005","unstructured":"Yeowell HN, Walker LC, Neumann LM (2005) An Ehlers-Danlos syndrome type VIA patient with cystic malformations of the meninges. Eur J Dermatol 15(5):353\u2013358","journal-title":"Eur J Dermatol"},{"issue":"1\u20132","key":"9_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ymgme.2005.04.014","volume":"86","author":"C Giunta","year":"2005","unstructured":"Giunta C, Randolph A, Steinmann B (2005) Mutation analysis of the PLOD1 gene: an efficient multistep approach to the molecular diagnosis of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA). Mol Genet Metab 86(1\u20132):269\u2013276","journal-title":"Mol Genet Metab"},{"issue":"5","key":"9_CR31","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.ajhg.2008.04.001","volume":"82","author":"A Abu","year":"2008","unstructured":"Abu A et al (2008) Deleterious mutations in the Zinc-Finger 469 gene cause brittle cornea syndrome. Am J Hum Genet 82(5):1217\u20131222","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2011.05.007","volume":"88","author":"EM Burkitt Wright","year":"2011","unstructured":"Burkitt Wright EM et al (2011) Mutations in PRDM5 in brittle cornea syndrome identify a pathway regulating extracellular matrix development and maintenance. Am J Hum Genet 88(6):767\u2013777","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9_CR33","doi-asserted-by":"publisher","first-page":"e4273","DOI":"10.1371\/journal.pone.0004273","volume":"4","author":"N Meani","year":"2009","unstructured":"Meani N et al (2009) The tumor suppressor PRDM5 regulates Wnt signaling at early stages of zebrafish development. PLoS One 4(1):e4273","journal-title":"PLoS One"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/0471221929.ch9","volume-title":"Connective tissue and its heritable disorders","author":"B Steinmann","year":"2002","unstructured":"Steinmann B, Royce P, Superti-Furga A (2002) The Ehlers-Danlos syndrome. In: Royce P, Steinmann B (eds) Connective tissue and its heritable disorders. Wiley-Liss, New York, pp 431\u2013523"},{"issue":"11","key":"9_CR35","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/humu.21355","volume":"31","author":"F Malfait","year":"2010","unstructured":"Malfait F et al (2010) Musculocontractural Ehlers-Danlos Syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene. Hum Mutat 31(11):1233\u20131239","journal-title":"Hum Mutat"},{"issue":"6","key":"9_CR36","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/ajmg.a.33498","volume":"152A","author":"T Kosho","year":"2010","unstructured":"Kosho T et al (2010) A new Ehlers-Danlos syndrome with craniofacial characteristics, multiple congenital contractures, progressive joint and skin laxity, and multisystem fragility-related manifestations. Am J Med Genet A 152A(6):1333\u20131346","journal-title":"Am J Med Genet A"},{"issue":"8","key":"9_CR37","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/humu.21300","volume":"31","author":"N Miyake","year":"2010","unstructured":"Miyake N et al (2010) Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. Hum Mutat 31(8):966\u2013974","journal-title":"Hum Mutat"},{"issue":"8","key":"9_CR38","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/ajmg.a.34115","volume":"155A","author":"K Shimizu","year":"2011","unstructured":"Shimizu K et al (2011) Delineation of dermatan 4-O-sulfotransferase 1 deficient Ehlers-Danlos syndrome: observation of two additional patients and comprehensive review of 20 reported patients. Am J Med Genet A 155A(8):1949\u20131958","journal-title":"Am J Med Genet A"},{"issue":"4","key":"9_CR39","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1073\/pnas.87.4.1342","volume":"87","author":"E Quentin","year":"1990","unstructured":"Quentin E et al (1990) A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci U S A 87(4):1342\u20131346","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR40","doi-asserted-by":"crossref","unstructured":"Malfait F, Kariminejad A, Van Damme T, Gauche C, Syx D, Merhi-Soussi F, Gulberti S, Symoens S, Vanhauwaert S, Willaert A, Bozorgmehr B, Kariminejad MH, Ebrahimiadib N, Hausser I, Huysseune A, Fournel-Gigleux S, De Paepe A (2013) Defective initiation of glycosaminoglycan synthesis due to B3GALT6 mutations causes a pleiotropic Ehlers-Danlos syndrome-like connective tissue disorder. Am J Hum Genet 2013 May 7 (E-pub ahead of print)","DOI":"10.1016\/j.ajhg.2013.04.016"},{"key":"9_CR41","doi-asserted-by":"crossref","unstructured":"Nakajima M, Mizumoto S, Miyake N, Kogawa R, Iida A, Ito H, Kitoh H, Hirayama A, Mitsubuchi H, Miyazaki O, Kosaki R, Horikawa R, Lai A, Mendoza-Londono R, Dupuis L, Chitayat D, Howard A, Leal GF, Cavalcanti D, Tsurusaki Y, Saitsu H, Watanabe S, Lausch E, Unger S, Bonaf\u00e9 L, Ohashi H, Superti-Furga A, Matsumoto N, Sugahara K, Nishimura G, Ikegawa S (2013) Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders. Am J Hum Genet 2013 May 7 (E-pub ahead of print)","DOI":"10.1016\/j.ajhg.2013.04.003"},{"issue":"6","key":"9_CR42","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.ajhg.2008.05.001","volume":"82","author":"C Giunta","year":"2008","unstructured":"Giunta C et al (2008) Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome\u2013an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13. Am J Hum Genet 82(6):1290\u20131305","journal-title":"Am J Hum Genet"},{"issue":"2","key":"9_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ajhg.2011.12.004","volume":"90","author":"M Baumann","year":"2012","unstructured":"Baumann M et al (2012) Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. Am J Hum Genet 90(2):201\u2013216","journal-title":"Am J Hum Genet"},{"issue":"19","key":"9_CR44","doi-asserted-by":"publisher","first-page":"19259","DOI":"10.1074\/jbc.M414698200","volume":"280","author":"WA Cabral","year":"2005","unstructured":"Cabral WA et al (2005) Mutations near amino end of alpha 1(I) collagen cause combined OI\/EDS by interference with N-propeptide processing. J Biol Chem 280(19):19259\u201319269","journal-title":"J Biol Chem"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1750-1172-8-78","volume":"8","author":"F Malfait","year":"2013","unstructured":"Malfait F, Symoens S, Goemans N, Gyftodimou Y, Holmberg E, L\u00f3pez-Gonz\u00e1lez V, Mortier G, Nampoothiri S, Petersen MB, De Paepe A (2013) Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta\/Ehlers-Danlos Syndrome overlap syndrome. Orphanet J Rare Dis 8:78","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"9_CR46","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1074\/jbc.M511830200","volume":"281","author":"E Makareeva","year":"2006","unstructured":"Makareeva E et al (2006) Molecular mechanism of alpha 1(I)-osteogenesis imperfecta\/Ehlers-Danlos syndrome: unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix. J Biol Chem 281(10):6463\u20136470","journal-title":"J Biol Chem"},{"issue":"1","key":"9_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ajmg.a.30299","volume":"131","author":"F Malfait","year":"2004","unstructured":"Malfait F et al (2004) The natural history, including orofacial features of three patients with Ehlers-Danlos syndrome, dermatosparaxis type (EDS type VIIC). Am J Med Genet A 131(1):18\u201328","journal-title":"Am J Med Genet A"},{"issue":"1","key":"9_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/1523-1747.ep12477969","volume":"66","author":"GE Pierard","year":"1976","unstructured":"Pierard GE, Lapiere M (1976) Skin in dermatosparaxis. Dermal microarchitecture and biomechanical properties. J Invest Dermatol 66(1):2\u20137","journal-title":"J Invest Dermatol"},{"issue":"3","key":"9_CR49","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ng0692-214","volume":"1","author":"BV Nusgens","year":"1992","unstructured":"Nusgens BV et al (1992) Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis. Nat Genet 1(3):214\u2013217","journal-title":"Nat Genet"},{"issue":"5","key":"9_CR50","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1086\/420794","volume":"74","author":"U Schwarze","year":"2004","unstructured":"Schwarze U et al (2004) Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet 74(5):917\u2013930","journal-title":"Am J Hum Genet"},{"issue":"7","key":"9_CR51","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1136\/jmg.2005.038224","volume":"43","author":"F Malfait","year":"2006","unstructured":"Malfait F et al (2006) Total absence of the alpha2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems. J Med Genet 43(7):e36","journal-title":"J Med Genet"},{"issue":"4","key":"9_CR52","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1086\/302859","volume":"66","author":"L Nuytinck","year":"2000","unstructured":"Nuytinck L et al (2000) Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. Am J Hum Genet 66(4):1398\u20131402","journal-title":"Am J Hum Genet"},{"issue":"4","key":"9_CR53","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/humu.20455","volume":"28","author":"F Malfait","year":"2007","unstructured":"Malfait F et al (2007) Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. Hum Mutat 28(4):387\u2013395","journal-title":"Hum Mutat"},{"issue":"4","key":"9_CR54","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/humu.20456","volume":"28","author":"WA Cabral","year":"2007","unstructured":"Cabral WA et al (2007) Y-position cysteine substitution in type I collagen (alpha1(I) R888C\/p.R1066C) is associated with osteogenesis imperfecta\/Ehlers-Danlos syndrome phenotype. Hum Mutat 28(4):396\u2013405","journal-title":"Hum Mutat"},{"issue":"1","key":"9_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1399-0004.2007.00926.x","volume":"73","author":"A Lund","year":"2008","unstructured":"Lund A et al (2008) A novel arginine-to-cysteine substitution in the triple helical region of the alpha1(I) collagen chain in a family with an osteogenesis imperfecta\/Ehlers-Danlos phenotype. Clin Genet 73(1):97\u2013101","journal-title":"Clin Genet"},{"issue":"5","key":"9_CR56","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1172\/JCI22760","volume":"115","author":"RC Gensure","year":"2005","unstructured":"Gensure RC et al (2005) A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders. J Clin Invest 115(5):1250\u20131257","journal-title":"J Clin Invest"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1172-6-46","volume":"6","author":"M Rohrbach","year":"2011","unstructured":"Rohrbach M et al (2011) Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation. Orphanet J Rare Dis 6:46","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"9_CR58","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1399-6576.2007.01416.x","volume":"51","author":"P Faber","year":"2007","unstructured":"Faber P et al (2007) The successful use of recombinant factor VIIa in a patient with vascular-type Ehlers-Danlos syndrome. Acta Anaesthesiol Scand 51(9):1277\u20131279","journal-title":"Acta Anaesthesiol Scand"},{"issue":"10","key":"9_CR59","first-page":"869","volume":"62","author":"RK Freeman","year":"1996","unstructured":"Freeman RK, Swegle J, Sise MJ (1996) The surgical complications of Ehlers-Danlos syndrome. Am Surg 62(10):869\u2013873","journal-title":"Am Surg"},{"issue":"2","key":"9_CR60","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0741-5214(87)90133-9","volume":"5","author":"DF Cikrit","year":"1987","unstructured":"Cikrit DF, Miles JH, Silver D (1987) Spontaneous arterial perforation: the Ehlers-Danlos specter. J Vasc Surg 5(2):248\u2013255","journal-title":"J Vasc Surg"},{"issue":"1","key":"9_CR61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jvs.2005.03.053","volume":"42","author":"GS Oderich","year":"2005","unstructured":"Oderich GS et al (2005) The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg 42(1):98\u2013106","journal-title":"J Vasc Surg"},{"issue":"10","key":"9_CR62","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM200003093421001","volume":"342","author":"M Pepin","year":"2000","unstructured":"Pepin M et al (2000) Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 342(10):673\u2013680","journal-title":"N Engl J Med"}],"container-title":["Advances in Experimental Medicine and Biology","Progress in Heritable Soft Connective Tissue Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-7893-1_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T08:37:25Z","timestamp":1716453445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-7893-1_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,14]]},"ISBN":["9789400778924","9789400778931"],"references-count":62,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-7893-1_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,14]]},"assertion":[{"value":"14 December 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}